glp1 gip tirzepatide Compounded for Women led and built for women Frontiers | GLP-1/GIP dual agonist

10.1016/j.biopha.2024.117081 58 HuK.LiaoX

Papadimitrakopoulou V, Figlin R, Garland L, Von Hoff D, Kris M, Purdom M, Brown GL, Maack C, Macpherson J and Henner WD

personal or family history of medullary thyroid carcinoma or MEN2 (a class-level GLP-1 caution that may extend to combination products)

Zepbound is FDA-approved for adults with a body mass index (BMI) of 30 kg/m or greater (obesity), or a BMI of 27 kg/m or greater (overweight) with at least one weight-related comorbidity such as hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease

Best taken before, after, or before meals as needed